Salarius Pharmaceuticals Inc (SLRX)
2.38
-0.07
(-2.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.04
-0.34
(-14.29%)
After-Hours: 20:00
Salarius Pharmaceuticals Total Liabilities (Quarterly): 1.234M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.234M |
| December 31, 2023 | 1.299M |
| September 30, 2023 | 2.320M |
| June 30, 2023 | 3.642M |
| March 31, 2023 | 4.496M |
| December 31, 2022 | 4.266M |
| September 30, 2022 | 3.110M |
| June 30, 2022 | 2.770M |
| March 31, 2022 | 2.092M |
| December 31, 2021 | 2.111M |
| September 30, 2021 | 1.612M |
| June 30, 2021 | 1.554M |
| March 31, 2021 | 1.990M |
| December 31, 2020 | 2.773M |
| September 30, 2020 | 2.457M |
| June 30, 2020 | 1.707M |
| March 31, 2020 | 2.063M |
| December 31, 2019 | 3.314M |
| September 30, 2019 | 4.721M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.036M |
| March 31, 2019 | 0.9111M |
| December 31, 2018 | 1.107M |
| September 30, 2018 | 2.888M |
| June 30, 2018 | 3.803M |
| March 31, 2018 | 4.145M |
| December 31, 2017 | 5.887M |
| September 30, 2017 | 5.026M |
| June 30, 2017 | 5.125M |
| March 31, 2017 | 3.278M |
| December 31, 2016 | 3.898M |
| September 30, 2016 | 3.924M |
| June 30, 2016 | 3.413M |
| March 31, 2016 | 3.082M |
| December 31, 2015 | 2.877M |
| September 30, 2015 | 2.762M |
| June 30, 2015 | 2.557M |
| March 31, 2015 | 1.863M |
| September 30, 2014 | 0.8033M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.036M
Minimum
Jun 2019
4.721M
Maximum
Sep 2019
2.528M
Average
2.216M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.884M |
| Shareholders Equity (Quarterly) | 3.650M |